Endocrine, metabolic and immune disorders - drug targets -Impact Score, Ranking



Endocrine, metabolic and immune disorders - drug targets ranking
Journal Rank11874
Impact Score1.97
H-Index60
SJR0.427

About Endocrine, metabolic and immune disorders - drug targets

Endocrine, metabolic and immune disorders - drug targets is a reputed research journal publish the research in the field/area related to Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3). It is published by Bentham Science Publishers B.V.. The journal has an h-index of 60. The overall rank of this journal is 11874. The more details like ISSN, Journal Quartile, SJR Score, ISSN, and other important details are provided in the following section.



Important Metrics

Journal TitleEndocrine, Metabolic and Immune Disorders - Drug Targets
PublisherBentham Science Publishers B.V.
ISSN18715303
SJR0.427
H-Index60
CountryUnited Arab Emirates
QuartileQ3
Online Submission Submit

Endocrine, metabolic and immune disorders - drug targets Impact Score 2024

The latest impact score of Endocrine, metabolic and immune disorders - drug targets is 1.97.


Credit & Source: Scopus.



More journals

'